Congratulations to graduate student Matthew Boudreau for being awarded a prestigious fellowship from NCI!

Matthew Boudreau, a chemistry PhD candidate in the CCIL Deputy Director Paul Hergenrother’s lab, has been awarded the prestigious F99/K00 grant from the National Cancer Institute (NCI). Boudreau’s research has centered around a novel therapeutic, ERSO, that successfully eradicates hormone-positive (ER+) breast cancer in multiple preclinical mouse models, and continues to be translated towards the clinic. […]

A compound for breast cancer discovered and developed in the Hergenrother and Shapiro labs has been licensed to Bayer

Paul Hergenrother helps discover cancer compound now in licensing deal. Researchers affiliated with the Cancer Center at Illinois discovered a novel small molecule compound that is now the subject of a new global licensing agreement between the pharmaceutical company Bayer AG and the cancer drug development company Systems Oncology LLC. Read the entire LAS story […]

Congratulations to Kristen Muñoz for being awarded a position on the NIH Chemistry-Biology Interface Training Grant!

Gram-negative bacteria have emerged that are resistant to most antibiotics, a troubling trend since a new class of antibiotics for Gram-negative pathogens has not been introduced in the clinic in 50 years. Central to the issue with discovering novel antibiotics for Gram-negative bacteria is the limited understanding of the physicochemical features that affect cell-membrane permeability and […]